FRNM Freenome, Inc. NASDAQ · United States

Freenome (FRNM) news

Freenome, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker FRNM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Freenome news

We have not published a story on Freenome yet. When there is news, it will appear here.

Freenome annual financials

Line	FY2025
Net income (loss)	$837,468
Cash from operations	-$864,653
Cash and equivalents	$865,031

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $437,369.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Freenome

What is the ticker symbol of Freenome?

Freenome, Inc. trades under the ticker FRNM on NASDAQ.

Where is Freenome listed?

Freenome, Inc. is listed on NASDAQ.

Which country or territory is Freenome listed under?

Our directory records Freenome, Inc. under United States.

Does aibio.space cover Freenome?

aibio.space lists Freenome, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Is Freenome profitable?

Freenome, Inc. reported net income of $837,468 for the fiscal year ended Dec 31, 2025, and used $864,653 of cash in operations, per its annual report to the SEC.

How much cash does Freenome have?

$437,369 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: Freenome

Members talk about Freenome (FRNM). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Freenome, newest first. Each line links the filing it comes from.

Jul 24, 2026Legal
Reported a change of independent auditor. SEC Form 8-K (Items 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,8.01,9.01). Source
Jul 20, 2026Listings
Filed to remove its shares from exchange listing. SEC Form 25-NSE. Source
Jun 17, 2026Financings
Filed a final prospectus for a securities offering. SEC Form 424B4. Source
May 19, 2026Mergers
Reported a merger or acquisition agreement. SEC Form 425. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:FRNM on TradingView.

Listing details

Company: Freenome, Inc.
Ticker: FRNM
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction